Unlearn and Trace Neuroscience Collaborate to Enhance ALS Clinical Trials
Unlearn and Trace Neuroscience Collaborate to Enhance ALS Clinical Trials Unlearn®, a leader in AI-powered solutions for clinical trials, has announced a strategic collaboration with Trace Neuroscience, a biotechnology company…
Gameday Men’s Health Appoints Dr. Haleem Mohammed as CMO to Lead National Expansion
Gameday Men’s Health Appoints Dr. Haleem Mohammed as CMO to Lead National Expansion Gameday Men’s Health, a leading men’s health clinic dedicated to redefining wellness through cutting-edge treatments and personalized…
Sydnexis Receives Positive CHMP Opinion for SYD-101 in Europe to Slow Pediatric Myopia Progression
Sydnexis Receives Positive CHMP Opinion for SYD-101 in Europe to Slow Pediatric Myopia Progression Sydnexis, Inc. a pre-commercial stage biopharmaceutical company specializing in ophthalmic therapeutics, has announced a significant regulatory…
$23.3Bn Antibody-Drug Conjugate Market Trends & Forecasts, 2035: 530+ Therapies, 140+ Developers
$23.3Bn Antibody-Drug Conjugate Market Trends & Forecasts, 2035: 530+ Therapies, 140+ Developers The antibody-drug conjugate (ADC) market is poised for significant growth, with projections indicating an increase from USD 7.72…
Align Technology Launches Invisalign® With Mandibular Advancement for Class II Correction
Align Technology Launches Invisalign® With Mandibular Advancement for Class II Correction Align Technology, Inc. (Nasdaq: ALGN), a globally recognized medical device company specializing in digital orthodontics and restorative dentistry, has…
MANSCAPED Unveils TCS Ball Hero Bundle for Testicular Cancer Awareness
MANSCAPED Unveils TCS Ball Hero Bundle for Testicular Cancer Awareness MANSCAPED, the global leader in men’s grooming, has built a reputation not only for its innovative grooming products and clever…
Mirion Enhances Radiopharmaceutical Production with Cutting-Edge Apex-Guard Software
Mirion Enhances Radiopharmaceutical Production with Cutting-Edge Apex-Guard Software Mirion Technologies (NYSE: MIR), a global leader in radiation safety solutions, has announced the latest release of its Apex-Guard gamma spectroscopy software.…
Devonian Announces Delay in Financial Results Release
Devonian Announces Delay in Financial Results Release Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical-stage biopharmaceutical company specializing in the development of innovative therapies…
ENHERTU Phase 3 DESTINY-Gastric05 Trial Starts for Untreated HER2+ Advanced Gastric Cancer
ENHERTU Phase 3 DESTINY-Gastric05 Trial Starts for Untreated HER2+ Advanced Gastric Cancer The first patient has been successfully dosed in the DESTINY-Gastric05 phase 3 trial, which aims to evaluate the…
LucyRx Unveils Bold Brand Identity, Celebrates Key Milestones to Simplify PBM and Enhance Patient Care
LucyRx Unveils Bold Brand Identity, Celebrates Key Milestones to Simplify PBM and Enhance Patient Care LucyRx, a next-generation pharmacy benefit manager (PBM), is shaking up the landscape of prescription care…
Omeros Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results
Omeros Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results Omeros Corporation has announced its recent developments, clinical updates, and financial results for the fourth quarter and full year ended…
Lilly’s RNA Silencer Achieves Nearly 94% Reduction in Key Cardiovascular Biomarker
Lilly’s RNA Silencer Achieves Nearly 94% Reduction in Key Cardiovascular Biomarker Eli Lilly has made a groundbreaking advancement in cardiovascular medicine with its investigational small interfering RNA (siRNA) therapeutic, lepodisiran,…